Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tiziana Life Sciences Ltd (NQ: TLSA )

0.9300 +0.0200 (+2.20%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 82,119
Open 0.9100
Bid (Size) 0.9001 (8)
Ask (Size) 0.9400 (1)
Prev. Close 0.9100
Today's Range 0.9010 - 0.9500
52wk Range 0.4100 - 1.740
Shares Outstanding 194,612,289
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Tesla Reclaims $1 Trillion Market Cap For First Time Since 2022 In Huge Trump Run
Tesla stock is on pace for its best weekly performance since January 2023. 
Via Investor's Business Daily
Topics Government
Exposures Political
Tesla Surges To 15-Month High On Election; Musk-Trump Alliance In Focus
Tesla stock is set to hit a 15-month high. 
Via Investor's Business Daily

Performance

YTD
+63.13%
+63.13%
1 Month
-2.09%
-2.09%
3 Month
-31.18%
-31.18%
6 Month
+49.35%
+49.35%
1 Year
+52.46%
+52.46%

More News

Read More
Cathie Wood Sells Tesla Before Election; Musk Cabinet Position "Not What Shareholders Want To See"
Via Investor's Business Daily
Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Elon Musk May Unveil Tesla's Robotaxi, But Consumers Respond With 'Ehhh,' New Study Reveals Skepticism, Need For Trust-Building
Via Benzinga
Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tiziana Life Sciences Appoints New Chief Executive Officer
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
The 3 Best EV Stocks to Buy in August 2024
Via InvestorPlace
Tiziana Life Sciences Granted FDA Fast Track Designation
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tiziana Receives $3.4 Million in Non-Dilutive Funding
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tiziana Life Sciences adds to treasury with $3.4 million in non-dilutive funding
Via News Direct
Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer’s Disease with Foralumab
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclerosis
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
Via FinancialNewsMedia
Exposures Product Safety
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple Sclerosis Patients Receiving Intranasal Foralumab
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
From FN Media Group LLC
Via GlobeNewswire
Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intranasal Foralumab
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis Research
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
EXCLUSIVE: Top Tesla Options Trades Recommended By Trading Expert
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.